CooperCompanies Acquires Generate Life Sciences

November 10, 2021

CooperCompanies agreed to acquire Generate Life Sciences from GI Partners for approximately $1.6 billion. The deal expands CooperSurgical’s fertility, donor-gamete and newborn stem cell (cord blood & tissue) offerings; Generate reported roughly $250 million in trailing twelve-month revenue and will be integrated into CooperSurgical pending customary closing conditions.

Buyers
CooperCompanies
Targets
Generate Life Sciences
Sellers
GI Partners
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.